ENTPD1 and neoplasm: Organoids derived from patients with a more elevated expression of high-affinity neoantigens (new tumor-specific antigens) on the major histocompatibility complex I (MHC I) displayed a significant increase in the antitumor activity of CD-39+ CD-8+ tumor-infiltrating lymphocytes (TILs).